Francesca Wanda Rossi Selected Research

NSC48478

7/2015

Discovery of new small molecules inhibiting 67 kDa laminin receptor interaction with laminin and cancer cell invasion.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Francesca Wanda Rossi Research Topics

Disease

8	Inflammation (Inflammations) 10/2022 - 11/2006
5	Systemic Scleroderma (Systemic Sclerosis) 03/2024 - 01/2017
5	Neoplasms (Cancer) 10/2022 - 07/2011
4	Autoimmune Diseases (Autoimmune Disease) 03/2024 - 01/2017
4	Rheumatoid Arthritis 01/2021 - 12/2018
3	Asthma (Bronchial Asthma) 01/2024 - 06/2021
3	Eosinophilia 01/2024 - 04/2021
3	Angioedema 07/2023 - 04/2021
2	Fibrosis (Cirrhosis) 03/2024 - 06/2015
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 04/2023 - 07/2022
2	Common Variable Immunodeficiency 12/2020 - 01/2019
1	Rhinitis 01/2024
1	Hypersensitivity (Allergy) 01/2024
1	Rhinosinusitis 01/2024
1	Melanoma (Melanoma, Malignant) 10/2023
1	Nervous System Diseases (Neurological Disorders) 07/2023
1	Neurologic Manifestations (Neurological Manifestations) 07/2023
1	Calcinosis Cutis 04/2023
1	Skin Manifestations 04/2023
1	Hereditary Angioedemas 01/2023
1	Macrophage Activation Syndrome 01/2023
1	Mastocytosis 08/2021
1	Systemic Mastocytosis 08/2021
1	Vasculitis (Vasculitides) 06/2021
1	Polyps 06/2021
1	Weight Gain 04/2021
1	Urticaria (Hives) 04/2021
1	Hemorrhage 02/2021
1	Thrombosis (Thrombus) 02/2021
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 02/2021
1	Porcine Reproductive and Respiratory Syndrome (PRRS) 01/2021
1	Pulmonary Hypertension 06/2020
1	Right Ventricular Dysfunction 06/2020
1	Pulmonary Arterial Hypertension 06/2020
1	Lung Diseases (Lung Disease) 05/2020
1	Hyperplasia 01/2019
1	Cytopenia 01/2019
1	Reinfection 01/2019
1	Primary Immunodeficiency Diseases 01/2019
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2019

Drug/Important Bio-Agent (IBA)

4	AutoantibodiesIBA 03/2024 - 01/2017
4	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 01/2018 - 07/2011
3	Formyl Peptide Receptors (Formyl Peptide Receptor)IBA 03/2024 - 01/2018
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2021 - 11/2006
2	Biomarkers (Surrogate Marker)IBA 04/2023 - 10/2022
2	VaccinesIBA 01/2023 - 07/2022
2	Vascular Endothelial Growth FactorsIBA 08/2021 - 11/2006
2	CytokinesIBA 01/2020 - 01/2020
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2018 - 01/2018
2	VitronectinIBA 06/2015 - 08/2013
1	AllergensIBA 01/2024
1	benralizumabIBA 01/2024
1	Conditioned Culture MediaIBA 10/2023
1	Colony-Stimulating Factors (Colony Stimulating Factor)IBA 10/2023
1	Peroxidase (Myeloperoxidase)IBA 10/2023
1	Tissue Plasminogen Activator (Alteplase)FDA Link 07/2023
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 07/2023
1	BradykininIBA 07/2023
1	Phosphates (Orthophosphate)IBA 04/2023
1	CalciumIBA 04/2023
1	belimumabIBA 04/2023
1	GlucocorticoidsIBA 04/2023
1	mRNA VaccinesIBA 01/2023
1	Interleukin-1 (Interleukin 1)IBA 01/2023
1	Secretory Phospholipases A2IBA 10/2022
1	EnzymesIBA 10/2022
1	Protein Isoforms (Isoforms)IBA 10/2022
1	COVID-19 VaccinesIBA 07/2022
1	Messenger RNA (mRNA)IBA 07/2022
1	AngiopoietinsIBA 08/2021
1	Codon (Codons)IBA 08/2021
1	Vascular Endothelial Growth Factor DIBA 08/2021
1	Vascular Endothelial Growth Factor CIBA 08/2021
1	mepolizumabIBA 06/2021
1	Monoclonal AntibodiesIBA 06/2021
1	Prednisone (Sone)FDA LinkGeneric 06/2021
1	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2021
1	Vitamin K FDA Link 02/2021
1	Antiphospholipid AntibodiesIBA 02/2021
1	Pattern Recognition ReceptorsIBA 01/2021
1	MicroRNAs (MicroRNA)IBA 12/2020
1	Therapeutic UsesIBA 10/2020
1	Vasodilator Agents (Vasodilators)IBA 06/2020
1	Immunoglobulin E (IgE)IBA 05/2020
1	Docosahexaenoic AcidsIBA 01/2020
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2020
1	Eicosapentaenoic AcidIBA 01/2020
1	LipidsIBA 01/2020
1	Immunoglobulin A (IgA)IBA 01/2019
1	Immunoglobulin G (IgG)IBA 01/2019
1	Immunoglobulins (Immunoglobulin)IBA 01/2019
1	Janus Kinase InhibitorsIBA 01/2019
1	Rituximab (Mabthera)FDA Link 01/2019
1	Janus KinasesIBA 01/2019
1	AntigensIBA 12/2018
1	Proteins (Proteins, Gene)FDA Link 12/2018
1	Interleukin-27 (Interleukin 27)IBA 12/2018
1	AntibodiesIBA 12/2018

Therapy/Procedure

5	Therapeutics 06/2021 - 01/2019
1	Immunotherapy 10/2022